process for treatment of amyotrophic lateral sclerosis, rheumatoid arthritis, parkinson's / tremor disease, multiple sclerosis, non-viral base cancers, alzheimer's disease, muscular dystrophy, inattention, hyperactivity disorder, regional pain syndrome complex, diabetes, neuropathic pain, rheumatoid arthritis, West Nile virus, fibromyalgia, shingles, gout, migraine, senile dementia, post polio syndrome, sudden deafness caused by virus, asthma, chronic pain of unknown origin and hepatitis c. The present invention relates to a composition and method for treating diseases associated with nerve demyelination, such as amyotrophic lateral sclerosis, ra, parkinson's / tremor disease, and multiple sclerosis, alzheimer's disease, amyotrophic lateral sclerosis, guillain-barre syndrome, atherosclerosis, schizophrenia, parkinson's / tremors, senile dementia, muscular dystrophy, inattention disorder, inactivity hyperactivity, complex regional pain syndrome, diabetes, neuropathic pain, rheumatoid arthritis fibromyalgia, copperium, gout, migraine, post-polio syndrome, sudden virus deafness, asthma, chronic pain of unknown origin, and hepatitis ce for the treatment of nonviral base cancers. By administering precise doses of an immunity-triggering agent and an activating bacterial antigen, patients suffering from amyotrophic lateral sclerosis, ra, ms, parkinson's / shivering disease, and prostate cancer, and others realized immediate beneficial results with no side effects.processo para tratamento de esclerose lateral amiotrófica, artrite reumatóide, doença de parkinson/tremores, esclerose múltipla, canceres de base não-virais, doença de alzheimer, distrofia muscular, transtorno do falta de atenção, falta de atenção e hiperatividade, síndrome de dor regional complexa, diabetes, dor neuropática, artrite reumatóide, vírus do nilo ocidental, fibromialgia, cobreiro, gota, enxaqueca, demência senil, síndrome pós-pólio, surdez subita causada por virus, asma, dor crônica de origem desconhe
